Low Dose Nivolumab With Chemotherapy vs Standard Chemotherapy as First-Line Treatment in Advanced or Metastatic NSCLC

Clinical trial NCT07050043 · RECRUITING

Trial details

NCT number: NCT07050043
Sponsor: Dr Arvindran A/L Alaga
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Carcinoma)First Line Therapy Locally Advanced/Metastatic NSCLC

Start date: 2025-05-19
Primary completion: 2030-12-31
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.